Literature DB >> 7507851

Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: modulation by heparin.

A J Strain1, G McGuinness, J S Rubin, S A Aaronson.   

Abstract

Keratinocyte growth factor (KGF/FGF-7) is a member of the fibroblast growth factor (FGF) superfamily. Unlike other members of the family, the biological activity of KGF appears to be restricted to epithelial cells. Here we have tested the activity of KGF, acidic fibroblast growth factor (aFGF), and basic fibroblast growth factor (bFGF) on normal adult rat and human hepatocytes and their modulation by heparin. Although more modest than the growth response to epidermal growth factor (EGF) and hepatocyte growth factor (HGF), recombinant KGF enhanced DNA synthesis in rat hepatocytes by two- to threefold. This stimulation occurred in the absence of serum and of other exogenous growth factors. Addition of heparin inhibited the KGF response. Although basic FGF showed little activity on rat hepatocytes, acidic FGF stimulated DNA synthesis by approximately twofold and was substantially enhanced by heparin. In contrast to rat cells, human hepatocytes consistently failed to respond to KGF, aFGF, or bFGF with or without heparin, under conditions where EGF and HGF stimulated DNA synthesis up to sixfold. These results indicate that KGF is capable of acting as a complete mitogen for rat hepatocytes in culture and that the activity is consistent with expression by these cells of a type II FGF receptor subtype, the KGF receptor. These observations suggest that KGF/aFGF together with proteoglycans may help regulate rat but not human liver growth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507851     DOI: 10.1006/excr.1994.1037

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate.

Authors:  J Dudás; G Ramadori; T Knittel; K Neubauer; D Raddatz; K Egedy; I Kovalszky
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

2.  Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract.

Authors:  R M Housley; C F Morris; W Boyle; B Ring; R Biltz; J E Tarpley; S L Aukerman; P L Devine; R H Whitehead; G F Pierce
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

3.  Role of protein kinase a pathway in epidermal growth factor-induced liver cell repair.

Authors:  M Kikuchi; T Y Ma; A S Tarnawski; H Shimada; I J Sarfeh
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

Review 4.  Keratinocyte growth factor: an androgen-regulated mediator of stromal-epithelial interactions in the prostate.

Authors:  D M Peehl; J S Rubin
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

5.  Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease.

Authors:  Heike Steiling; Marcus Mühlbauer; Frauke Bataille; Jürgen Schölmerich; Sabine Werner; Claus Hellerbrand
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

6.  Expression of fibroblast growth factor receptor genes in human hepatoma-derived cell lines.

Authors:  Nobuyuki Asada; Yoshiharu Tanaka; Yasutaka Hayashido; Shigeaki Toratani; Mikio Kan; Mikiya Kitamoto; Toshio Nakanishi; Goro Kajiyama; Kazuaki Chayama; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

7.  Activation of paracrine growth factors by heparan sulphate induced by glucocorticoid in A549 lung carcinoma cells.

Authors:  N Yevdokimova; R I Freshney
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Signals and cells involved in regulating liver regeneration.

Authors:  Liang-I Kang; Wendy M Mars; George K Michalopoulos
Journal:  Cells       Date:  2012-12-13       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.